Hepatitis

Featured Article
FDA Issues Warning for 3 Hepatitis C Virus Medications
The FDA has issued a drug safety warning about the use of 3 medications for hepatitis C virus among individuals with moderate to severe liver impairment.
How Statin Type Influences HCC Incidence, Mortality in Those With Viral Hepatitis
Researchers recently compared how the use of lipophilic or hydrophilic statins impacted hepatocellular carcinoma in patients with viral hepatitis.
Reduced Hep C Treatment Costs, Increased Manufacturer Revenue Under 340B
A recent study investigated whether drug manufacturers saw increased net revenue after reduced list prices for hepatitis C treatments and changes to discounts provided under the 340B program.

Newsfeed

FDA Issues Warning for 3 Hepatitis C Virus Medications
How Statin Type Influences HCC Incidence, Mortality in Those With Viral Hepatitis
Reduced Hep C Treatment Costs, Increased Manufacturer Revenue Under 340B
VA Close to Meeting Goal of Curing 100,000 Veterans of Hepatitis C
History of HCC Increases HCV Treatment Failure
State Prisons Fail To Offer Cure To Inmates With Hepatitis C
CDC Warns of Multi-State Hepatitis Outbreak
Direct-Acting Antivirals Impact on Liver Cancer Risk in Patients with HCV
View More

Interactive Features

How Hepatitis C Treatment Success Relates to Insulin Resistance
Does hepatitis C treatment success improve insulin resistance in patients with diabetes?
View More
Back to Top